Causaly

London, United Kingdom Founded: 2017 • Age: 9 yrs
AI-based data-mining tools for scientific evidence discovery are provided.

About Causaly

Causaly is a Healthcare company based in London (United Kingdom) founded in 2017. AI-based data-mining tools for scientific evidence discovery are provided. Causaly has raised $90.72 million across 5 funding rounds from investors including EBRD, Iconiq Capital and Index Ventures. The company has 62 employees. Its website causaly.com draws about 39 thousand monthly visits. Causaly offers products and services including AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its legal entity is CAUSALY LTD.

Company details

Causaly was founded in 2017 and is headquartered in London, United Kingdom. The company operates in the biomedical AI sector, where software is developed to extract evidence from academic publications, clinical trials, regulatory documents, patents, and other sources. Hidden causal relationships in biomedical data are identified and curated through this technology, supporting researchers in cause-and-effect analysis.

  • Headquarters London, United Kingdom
  • Employees 62
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website causaly.com
  • Social LinkedIn X
  • Legal Name Causaly Ltd
  • Date of Incorporation 17 May, 2018
  • Jurisdiction LONDON, ENGLAND
Key Metrics
  • Total Equity Funding
    $90.72M (USD)

    in 5 rounds

  • Latest Funding Round
    $60M (USD), Series B

    Jul 2023

  • Investors
    EBRD

    & 14 more

  • Employee Count
    62

Products & Services of Causaly

Causaly offers a comprehensive portfolio of products and services, including AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG.

AI Platform
AI Software

Unified system for life sciences R&D using AI and knowledge graphs.

Generative AI Copilot
AI Assistant

Tool for querying and analyzing biomedical data with citations.

Knowledge Graph
Data Management

High-precision graph for causal relationships in life sciences.

Enterprise Data Fabric
Data Integration

Platform to consolidate internal and external data for R&D.

Scientific RAG
Information Retrieval

System for accurate retrieval of life sciences information.

Funding Insights of Causaly

Causaly has successfully raised a total of $90.72M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $60 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $90.72M
  • Total Rounds 5
  • Last Round Series B β€” $60M
  • First Round $1.2M

    (Jul 2018)

  • Investors Count 15

All 5 funding rounds of Causaly with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2023$60MSeries B–Iconiq Capital
Oct 2022$7.72MSeries A––
–
May 2021$17MSeries A–Index Ventures
Nov 2019$4.8MSeries A–Pentech, EBRD
Jul 2018$1.2MSeed–Marathon Venture Capital
Valuation history

15 investors in total: 9 institutional and 6 angel.

Investors in Causaly

Causaly has secured backing from 15 investors, including venture fund and angel investors. Prominent investors backing the company include EBRD, Iconiq Capital and Index Ventures.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Provider of investment management and real asset services
iconiqcapital.comSan Francisco, United States
Venture capital investments in technology startups and entrepreneurs.
indexventures.com
Venture capital funding is provided to early-stage startups.
marathon.vcAthens, Greece
Venture capital funding is provided for early-stage software companies.
pentechvc.comEdinburgh, United Kingdom
Visionaries Club is engaged in venture capital investments for B2B tech startups.
visionaries.vcBerlin, Germany
Corporate advisory services are provided across multiple sectors.
1991ebrd.comLondon, United Kingdom
UK tech and offline companies are funded by Pentech.
pentech.vcEdinburgh, United Kingdom
Early-stage tech investments are made in Europe and Asia.
ebrdvcip.comLondon, United Kingdom
A pre-seed fund is managed to support early-stage founders.
emergecapital.vcLondon, United Kingdom

Olivier Pomel

Co-founder & CEO of Datadog, active angel investor in tech startups
unknown_107d9cdaa0af402c8
Premium access

Investor details for Causaly

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Causaly

46 people are tracked at Causaly (18 in leadership, 28 in team); the tracked headcount is 62.

NameRoleGroup
Isra Salim
VP ProductLeadership
Guilherme de Oliveira Pinheiro
Senior Vice President Global SalesLeadership
Marcel Karnstedt Hulpuş
Director Of Data And Semantic TechnologiesLeadership
Yiannis Kiachopoulos
Co-founder & CEOLeadership
Artur Saudabayev
Co-founder & CTOLeadership
Andy Grygiel
Chief Marketing OfficerLeadership
Matthew Polletta
Director Of Strategic AccountsLeadership
Stefanos Leptidis
Head Of Biomedical Information SciencesLeadership
Marco Costa
COOLeadership
Michael Zoidis
Head Of Product DesignLeadership
Alan Davies
Head Of IT SecurityLeadership
Maria Loufardaki
People DirectorLeadership
Chris Harrison
Talent PartnerLeadership
Mireia Puignou
People Operations PartnerLeadership
Damir Dosymbekov
Head Of ProductLeadership
Alexandra Lemacon
Senior Director, Life Sciences Strategy EMEALeadership
Dimitrios Michalakos
Director Of Application EngineeringLeadership
Rui Miguel Forte
Director Of Engineering (nlp/ml)Leadership
Mark Goodwin
Senior Staff Security EngineerTeam
Nikos Kalogridis
Software ArchitectTeam

26 more people are available in the full profile.

Premium access

Complete people profiles for Causaly

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Causaly

3 dated milestones of Causaly across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Causaly is founded.
  2. Funding First funding round of $1.2M.
  3. Funding Latest funding round, Series B, of $60.0M.

Web traffic of Causaly

The website of Causaly (causaly.com) receives about 38.8K visits a month.

  • Monthly visits
    38.8K

    ▲ 80% vs previous month

Similar websites

Websites whose visitors overlap most with Causaly. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
papersapp.com
100%
81.4K#493,194View details
scite.ai
56%
885.4K#61,043View details
scispace.com
54%
4.8M#12,888View details

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Causaly (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Causaly

Premium access

Complete news archive for Causaly

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Causaly

Causaly was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Causaly is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Causaly is a funded company, having raised a total of $90.72M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.2M, raised on Jul 2018.

Causaly has 62 employees.

Causaly was founded in 2017 and is headquartered in London, United Kingdom. The company operates in the biomedical AI sector, where software is developed to extract evidence from academic publications, clinical trials, regulatory documents, patents, and other sources. Hidden causal relationships in biomedical data are identified and curated through this technology, supporting researchers in cause-and-effect analysis.

Causaly offers AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG.

Causaly has 15 investors. Key investors include EBRD, Iconiq Capital, Index Ventures, Marathon Venture Capital, and Pentech.

Causaly operates through Causaly Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available